Treatment resulted in a rapid and highly significant reduction of oxysterol biomarkers in liver and serum.
← all excerpts
AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5.
1
—
—
Treatment resulted in a rapid and highly significant reduction of oxysterol biomarkers in liver and serum.